254 related articles for article (PubMed ID: 11900679)
1. Advances in imaging for pancreatic disease.
Del Frate C; Zanardi R; Mortele K; Ros PR
Curr Gastroenterol Rep; 2002 Apr; 4(2):140-8. PubMed ID: 11900679
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic carcinoma: imaging update 2001.
Freeny PC
Dig Dis; 2001; 19(1):37-46. PubMed ID: 11385250
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography of pancreatic masses.
Balthazar EJ; Chako AC
Am J Gastroenterol; 1990 Apr; 85(4):343-9. PubMed ID: 2158229
[TBL] [Abstract][Full Text] [Related]
4. [Angiography in pancreatic diseases].
Tsubogo Y
Saishin Igaku; 1970 Nov; 25(11):2318-26. PubMed ID: 4321260
[No Abstract] [Full Text] [Related]
5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
6. Efficiency and limitations of angiography in diseases of the pancreas.
Bücheler E; Boldt I
Rofo; 1975 Jul; 123(1):XXVII, XXX. PubMed ID: 176093
[No Abstract] [Full Text] [Related]
7. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and staging of pancreatic cancer by positron emission tomography.
Berberat P; Friess H; Kashiwagi M; Beger HG; Büchler MW
World J Surg; 1999 Sep; 23(9):882-7. PubMed ID: 10449814
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography of the pancreas.
Freeny PC
Clin Gastroenterol; 1984 Sep; 13(3):791-818. PubMed ID: 6091954
[No Abstract] [Full Text] [Related]
10. Pancreatic imaging: current and emerging technologies.
Nichols MT; Russ PD; Chen YK
Pancreas; 2006 Oct; 33(3):211-20. PubMed ID: 17003640
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic imaging. Computed tomography and magnetic resonance imaging.
Thoeni RF; Blankenberg F
Radiol Clin North Am; 1993 Sep; 31(5):1085-113. PubMed ID: 8395697
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation.
Raman SP; Chen Y; Fishman EK
Semin Oncol; 2015 Feb; 42(1):40-58. PubMed ID: 25726051
[TBL] [Abstract][Full Text] [Related]
13. The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease.
Rajput A; Stellato TA; Faulhaber PF; Vesselle HJ; Miraldi F
Surgery; 1998 Oct; 124(4):793-7; discussion 797-8. PubMed ID: 9781003
[TBL] [Abstract][Full Text] [Related]
14. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.
Kauhanen S; Rinta-Kiikka I; Kemppainen J; Grönroos J; Kajander S; Seppänen M; Alanen K; Gullichsen R; Nuutila P; Ovaska J
J Nucl Med; 2015 Aug; 56(8):1163-8. PubMed ID: 26045314
[TBL] [Abstract][Full Text] [Related]
16. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations.
Sendler A; Avril N; Helmberger H; Stollfuss J; Weber W; Bengel F; Schwaiger M; Roder JD; Siewert JR
World J Surg; 2000 Sep; 24(9):1121-9. PubMed ID: 11036292
[TBL] [Abstract][Full Text] [Related]
18. Cancer of the pancreas: the best image for early detection--CT, MRI, PET or US?
Hanbidge AE
Can J Gastroenterol; 2002 Feb; 16(2):101-5. PubMed ID: 11875594
[TBL] [Abstract][Full Text] [Related]
19. [Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].
Zimny M; Schumpelick V
Chirurg; 2001 Sep; 72(9):989-94. PubMed ID: 11594284
[TBL] [Abstract][Full Text] [Related]
20. Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.
Pery C; Meurette G; Ansquer C; Frampas E; Regenet N
Gastroenterol Clin Biol; 2010 Sep; 34(8-9):465-74. PubMed ID: 20688444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]